New heart valve study aims to improve life for patients with narrowed aortic valve

NCT ID NCT06507579

Recruiting now Disease control Sponsor: Sahajanand Medical Technologies Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new heart valve called Hydra for people with severe aortic stenosis, a condition where the heart's main valve becomes narrow. About 250 participants will get the valve through a tube in an artery, and researchers will check how safe and effective it is for up to a year. They will also use a special heart monitor after patients go home to catch any hidden heart rhythm problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC VALVE STENOSIS

Contacts and locations

Locations

Castle Hill Hull
RECRUITING

Cottingham, HU16 5JQ, United Kingdom
Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust
RECRUITING

Sheffield, Yorkshire, S5 7AU, United Kingdom
Royal Papworth
NOT_YET_RECRUITING

Cambridge, CB2 0AY, United Kingdom
Royal Victoria Hospital
NOT_YET_RECRUITING

Belfast, BT12 6BA, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.